Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study
Abstract Background Tens of million cases of coronavirus disease-2019 (COVID-19) have occurred globally. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) attacks the respiratory system, causing pneumonia and lymphopenia in infected individuals. The aim of the present study is to inve...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-06-01
|
Series: | Virology Journal |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12985-021-01597-x |
id |
doaj-a5dbc002d0084c4e9aec0b0c4af33852 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Shi-Wei Yin Zheng Zhou Jun-Ling Wang Yun-Feng Deng Hui Jing Yi Qiu |
spellingShingle |
Shi-Wei Yin Zheng Zhou Jun-Ling Wang Yun-Feng Deng Hui Jing Yi Qiu Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study Virology Journal Asymptomatic COVID-19 Interleukin Lymphocyte subset SARS-CoV-2 Viral load |
author_facet |
Shi-Wei Yin Zheng Zhou Jun-Ling Wang Yun-Feng Deng Hui Jing Yi Qiu |
author_sort |
Shi-Wei Yin |
title |
Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study |
title_short |
Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study |
title_full |
Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study |
title_fullStr |
Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study |
title_full_unstemmed |
Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study |
title_sort |
viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with sars-cov-2 infection: a retrospective study |
publisher |
BMC |
series |
Virology Journal |
issn |
1743-422X |
publishDate |
2021-06-01 |
description |
Abstract Background Tens of million cases of coronavirus disease-2019 (COVID-19) have occurred globally. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) attacks the respiratory system, causing pneumonia and lymphopenia in infected individuals. The aim of the present study is to investigate the laboratory characteristics of the viral load, lymphocyte subset and cytokines in asymptomatic individuals with SARS-CoV-2 infection in comparison with those in symptomatic patients with COVID-19. Methods From January 24, 2020, to April 11, 2020, 48 consecutive subjects were enrolled in this study. Viral loads were detected by RT-PCR from throat-swab, sputum and feces samples. Lymphocyte subset levels of CD3 + , CD4 + , and CD8 + T lymphocytes, B cells and NK cells were determined with biological microscope and flow cytometric analysis. Plasma cytokines (IL2, IL4, IL5, IL6, IL8, IL10, TNF-α, IFN-α and IFN-γ) were detected using flow cytometer. Analysis of variance (ANOVA), Chi-square or Fisher's exact test and Pearson’s Correlation assay was used for all data. Results Asymptomatic (AS), mild symptoms (MS) and severe or critical cases (SCS) with COVID-19 were 11 (11/48, 22.9%), 26 (54.2%, 26/48) and 11 cases (11/48, 22.9%), respectively. The mean age of AS group (47.3 years) was lower than SCS group (63.5 years) (P < 0.05). Diabetes mellitus in AS, MS and SCS patients with COVID-19 were 0, 6 and 5 cases, respectively, and there was a significant difference between AS and SCS (P < 0.05). No statistical differences were found in the viral loads of SARS-CoV-2 between AS, MS and SCS groups on admission to hospital and during hospitalization. The concentration of CD 3 + T cells (P < 0.05), CD3 + CD4 + T cells (P < 0.05), CD3 + CD8 + T cells (P < 0.01), and B cells (P < 0.05) in SCS patients was lower than in AS and MS patients, while the level of IL-5 (P < 0.05), IL-6 (P < 0.05), IL-8 (P < 0.01) and IL-10 (P < 0.01), and TNF-α (P < 0.05) was higher. The age was negatively correlated with CD3 + T cells (P < 0.05), CD3 + CD4 + T cells (P < 0.05), and positively correlated with IL-2 (P < 0.001), IL-5 (P < 0.05), IL-6 (P < 0.05) IL-8 (P < 0.05), and IL-10 (P < 0.05). The viral loads were positively correlated with IL-2 (P < 0.001), IL-5 (P < 0.05), IL-6 (P < 0.05) IL-8 (P < 0.05) and IL-10 (P < 0.05), while negatively correlated with CD 3 + T cells (P < 0.05) and CD3 + CD4 + T cells (P < 0.05). Conclusions The viral loads are similar between asymptomatic, mild and severe or critical patients with COVID-19. The severity of COVID-19 may be related to underlying diseases such as diabetes mellitus. Lymphocyte subset and plasma cytokine levels may be as the markers to distinguish severely degrees of disease, and asymptomatic patients may be as an important source of infection for the COVID-19. |
topic |
Asymptomatic COVID-19 Interleukin Lymphocyte subset SARS-CoV-2 Viral load |
url |
https://doi.org/10.1186/s12985-021-01597-x |
work_keys_str_mv |
AT shiweiyin viralloadslymphocytesubsetsandcytokinesinasymptomaticmildlyandcriticalsymptomaticpatientswithsarscov2infectionaretrospectivestudy AT zhengzhou viralloadslymphocytesubsetsandcytokinesinasymptomaticmildlyandcriticalsymptomaticpatientswithsarscov2infectionaretrospectivestudy AT junlingwang viralloadslymphocytesubsetsandcytokinesinasymptomaticmildlyandcriticalsymptomaticpatientswithsarscov2infectionaretrospectivestudy AT yunfengdeng viralloadslymphocytesubsetsandcytokinesinasymptomaticmildlyandcriticalsymptomaticpatientswithsarscov2infectionaretrospectivestudy AT huijing viralloadslymphocytesubsetsandcytokinesinasymptomaticmildlyandcriticalsymptomaticpatientswithsarscov2infectionaretrospectivestudy AT yiqiu viralloadslymphocytesubsetsandcytokinesinasymptomaticmildlyandcriticalsymptomaticpatientswithsarscov2infectionaretrospectivestudy |
_version_ |
1721379712772603904 |
spelling |
doaj-a5dbc002d0084c4e9aec0b0c4af338522021-06-13T11:31:40ZengBMCVirology Journal1743-422X2021-06-011811910.1186/s12985-021-01597-xViral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective studyShi-Wei Yin0Zheng Zhou1Jun-Ling Wang2Yun-Feng Deng3Hui Jing4Yi Qiu5Shandong Provincial Public Health Clinical Center, Katharine Hsu International Research Institute of Infectious Disease, Shandong University Affiliated HospitalShandong Provincial Public Health Clinical Center, Katharine Hsu International Research Institute of Infectious Disease, Shandong University Affiliated HospitalDepartment of Clinical Laboratory, Shandong Provincial Public Health Clinical Center, Shandong University Affiliated HospitalDepartment of Clinical Laboratory, Shandong Provincial Public Health Clinical Center, Shandong University Affiliated HospitalShandong Provincial Public Health Clinical Center, Katharine Hsu International Research Institute of Infectious Disease, Shandong University Affiliated HospitalKey Laboratory of Birth Regulation and Control Technology of National Health Commission of China, Maternal and Child Health Care Hospital of Shandong ProvinceAbstract Background Tens of million cases of coronavirus disease-2019 (COVID-19) have occurred globally. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) attacks the respiratory system, causing pneumonia and lymphopenia in infected individuals. The aim of the present study is to investigate the laboratory characteristics of the viral load, lymphocyte subset and cytokines in asymptomatic individuals with SARS-CoV-2 infection in comparison with those in symptomatic patients with COVID-19. Methods From January 24, 2020, to April 11, 2020, 48 consecutive subjects were enrolled in this study. Viral loads were detected by RT-PCR from throat-swab, sputum and feces samples. Lymphocyte subset levels of CD3 + , CD4 + , and CD8 + T lymphocytes, B cells and NK cells were determined with biological microscope and flow cytometric analysis. Plasma cytokines (IL2, IL4, IL5, IL6, IL8, IL10, TNF-α, IFN-α and IFN-γ) were detected using flow cytometer. Analysis of variance (ANOVA), Chi-square or Fisher's exact test and Pearson’s Correlation assay was used for all data. Results Asymptomatic (AS), mild symptoms (MS) and severe or critical cases (SCS) with COVID-19 were 11 (11/48, 22.9%), 26 (54.2%, 26/48) and 11 cases (11/48, 22.9%), respectively. The mean age of AS group (47.3 years) was lower than SCS group (63.5 years) (P < 0.05). Diabetes mellitus in AS, MS and SCS patients with COVID-19 were 0, 6 and 5 cases, respectively, and there was a significant difference between AS and SCS (P < 0.05). No statistical differences were found in the viral loads of SARS-CoV-2 between AS, MS and SCS groups on admission to hospital and during hospitalization. The concentration of CD 3 + T cells (P < 0.05), CD3 + CD4 + T cells (P < 0.05), CD3 + CD8 + T cells (P < 0.01), and B cells (P < 0.05) in SCS patients was lower than in AS and MS patients, while the level of IL-5 (P < 0.05), IL-6 (P < 0.05), IL-8 (P < 0.01) and IL-10 (P < 0.01), and TNF-α (P < 0.05) was higher. The age was negatively correlated with CD3 + T cells (P < 0.05), CD3 + CD4 + T cells (P < 0.05), and positively correlated with IL-2 (P < 0.001), IL-5 (P < 0.05), IL-6 (P < 0.05) IL-8 (P < 0.05), and IL-10 (P < 0.05). The viral loads were positively correlated with IL-2 (P < 0.001), IL-5 (P < 0.05), IL-6 (P < 0.05) IL-8 (P < 0.05) and IL-10 (P < 0.05), while negatively correlated with CD 3 + T cells (P < 0.05) and CD3 + CD4 + T cells (P < 0.05). Conclusions The viral loads are similar between asymptomatic, mild and severe or critical patients with COVID-19. The severity of COVID-19 may be related to underlying diseases such as diabetes mellitus. Lymphocyte subset and plasma cytokine levels may be as the markers to distinguish severely degrees of disease, and asymptomatic patients may be as an important source of infection for the COVID-19.https://doi.org/10.1186/s12985-021-01597-xAsymptomaticCOVID-19InterleukinLymphocyte subsetSARS-CoV-2Viral load |